Literature DB >> 26410282

Induced sputum in young healthy children with cystic fibrosis.

Julian Forton1.   

Abstract

Young children with CF are often asymptomatic and non-productive, yet CF lung disease occurs early in life. Cough swabs are used routinely to sample bacteria from the CF respiratory tract in non-productive healthy children; bronchoscopy is used to definitively sample the lower airway, but is an invasive procedure. Induced sputum is a non-invasive approach to sampling the lower airway. The article concentrates on how well it is tolerated in children, how successful it is in identifying respiratory pathogens, and how it may be important in routine surveillance if 16S technology is to be used in the clinical forum.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Cystic Fibrosis; Induced sputum; Respiratory microbiome

Mesh:

Year:  2015        PMID: 26410282     DOI: 10.1016/j.prrv.2015.07.007

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  3 in total

1.  Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for predictive, preventive, and personalized medicine.

Authors:  Tao Zhu; Shanqun Li; Jiajia Wang; Chunfang Liu; Lei Gao; Yuzhen Zeng; Ruolin Mao; Bo Cui; Hong Ji; Zhihong Chen
Journal:  EPMA J       Date:  2020-11-04       Impact factor: 6.543

2.  The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx.

Authors:  R L Marsh; M Kaestli; A B Chang; M J Binks; C E Pope; L R Hoffman; H C Smith-Vaughan
Journal:  Microbiome       Date:  2016-07-07       Impact factor: 14.650

3.  The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.

Authors:  Katherine Ronchetti; Jo-Dee Tame; Christopher Paisey; Lena P Thia; Iolo Doull; Robin Howe; Eshwar Mahenthiralingam; Julian T Forton
Journal:  Lancet Respir Med       Date:  2018-05-16       Impact factor: 30.700

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.